CA2341308A1 - Proteine 3 de fixation latente au facteur $g(b) de croissance de transformation humain - Google Patents

Proteine 3 de fixation latente au facteur $g(b) de croissance de transformation humain Download PDF

Info

Publication number
CA2341308A1
CA2341308A1 CA002341308A CA2341308A CA2341308A1 CA 2341308 A1 CA2341308 A1 CA 2341308A1 CA 002341308 A CA002341308 A CA 002341308A CA 2341308 A CA2341308 A CA 2341308A CA 2341308 A1 CA2341308 A1 CA 2341308A1
Authority
CA
Canada
Prior art keywords
seq
gly
hltbp
nucleic acid
pro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002341308A
Other languages
English (en)
Inventor
Brian Taylor Edmonds
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2341308A1 publication Critical patent/CA2341308A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

L'invention concerne des composés d'acides nucléiques isolés codant des polypeptides et leurs fragments, lesdits polypeptides étant apparentés à la famille de la protéine de fixation latente à TGF.beta. humain (hLTBP). Elle concerne également des vecteurs et des cellules hôtes hétérologues transformées servant à exprimer lesdits polypeptides, un procédé d'utilisation desdits acides nucléiques et polypeptides afin d'inhiber des activités dépendantes de TGF.beta. in vitro ou in vivo, ainsi que des compositions pharmaceutiques contenant lesdits acides nucléiques ou polypeptides. Elle concerne également des méthodes mises en application afin d'identifier des composés se fixant audits polypeptides.
CA002341308A 1998-09-01 1999-08-30 Proteine 3 de fixation latente au facteur $g(b) de croissance de transformation humain Abandoned CA2341308A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9876698P 1998-09-01 1998-09-01
US60/098,766 1998-09-01
PCT/US1999/019436 WO2000012551A1 (fr) 1998-09-01 1999-08-30 PROTEINE 3 DE FIXATION LATENTE AU FACTEUR $G(b) DE CROISSANCE DE TRANSFORMATION HUMAIN

Publications (1)

Publication Number Publication Date
CA2341308A1 true CA2341308A1 (fr) 2000-03-09

Family

ID=22270787

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002341308A Abandoned CA2341308A1 (fr) 1998-09-01 1999-08-30 Proteine 3 de fixation latente au facteur $g(b) de croissance de transformation humain

Country Status (7)

Country Link
EP (1) EP1109829A4 (fr)
JP (1) JP2002535957A (fr)
AU (1) AU5900799A (fr)
CA (1) CA2341308A1 (fr)
HU (1) HUP0103201A2 (fr)
IL (1) IL141610A0 (fr)
WO (1) WO2000012551A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use

Also Published As

Publication number Publication date
EP1109829A1 (fr) 2001-06-27
WO2000012551A1 (fr) 2000-03-09
EP1109829A4 (fr) 2003-01-02
HUP0103201A2 (hu) 2001-12-28
IL141610A0 (en) 2002-03-10
JP2002535957A (ja) 2002-10-29
AU5900799A (en) 2000-03-21

Similar Documents

Publication Publication Date Title
US5928939A (en) Vascular endothelial growth factor-b and dna coding therefor
JP4124815B2 (ja) TGF−β型受容体cDNAおよびその用途
US6610510B1 (en) Morphogenic proteins
JP2003521893A (ja) 線維芽細胞増殖因子様ポリペプチド
WO1999037671A1 (fr) Gene et proteine associes au facteur de croissance des cellules endotheliales vasculaires
CA2324476A1 (fr) Traitement et prevention des affections vasculaires
CA2310987A1 (fr) Gene de la famille des ligands du tnf
CA2295439A1 (fr) Proteine de mammifere de type facteur de croissance nerveuse
EP0962530A2 (fr) Séquence du gène codant pour la protéine scarface 1 apparentée a l'angiopoiétine
WO1999026976A1 (fr) Gene de la famille des ligands du facteur de necrose des tumeurs (tnf)
EP0962466A1 (fr) Scarface 3, gène liée aux angiopoietins
WO2000059940A2 (fr) Gene et proteine lies au facteur de croissance d'origine plaquettaire
CA2341308A1 (fr) Proteine 3 de fixation latente au facteur $g(b) de croissance de transformation humain
WO1999033967A2 (fr) Nouvel acide nucleique et nouveau polypeptide
EP0984063A2 (fr) Gene et proteine apparentee au vegf
US20020026043A1 (en) Desert hedgehog related nucleic acids and proteins
EP0995759A1 (fr) Scarface 2, gène liée aux Angiopoietins
AU753400C (en) Orphan receptors
MXPA01001929A (en) HUMAN LATENT TRANSFORMING GROWTH FACTOR-&bgr;BINDING PROTEIN 3
AU2008201780B2 (en) Fibroblast growth factor-like polypeptides
WO2001074860A2 (fr) Techniques d'identification de ligands d'integrine par utilisation d'expression de gene differentielle
US20030228653A1 (en) Novel orphan cytokine receptor polypeptides
WO1999023110A1 (fr) Gene hptlg issu de l'hypothalamus humain
WO2000041537A2 (fr) Utilisation de la proteine desert hedgehog
HK1144437A (en) Fibroblast growth factor-like polypeptides

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued